With trauma patients just a few minutes delay in treatment can make the difference between life and death. However South Chicago has been without a trauma center since 1991. This means trauma patients have to be transported nearly 10 miles away to receive the specialized services they need. The $270 million makeover happening at the University of Chicago's Hyde Park campus seeks to resolve that issue. The new $39 million adult emergency department that opened at U Chicago Medicine in December will become an integrated trauma care facility within the next few months.
Read More
0 Comments Click here to read/write comments
Tags: Midwest, University of Chicago, BioResearch Product Faire Event, Chicago, Front Line event, laboratory equipment, lab suppliers, UChicago, BioResearch Product Faire, Laboratory product sales, microbiome immunotherapy, University construction, medical lab
The University of Chicago is receiving $100 million from Craig Duchossois, his wife, and Janet Duchossois and The Duchossois Family Foundation. The funding will be used to establish a new life science institute that will focus on the development of a “new science of wellness.” As the name indicates, The Duchossois Family Institute: Harnessing the Microbiome and Immunity for Human Health, will work to accelerate research and interventions based on how the human immune system, microbiome and genetics interact to maintain health.
Read More
0 Comments Click here to read/write comments
Tags: Midwest, microbiome, immunotherapy, University of Chicago, BioResearch Product Faire Event, Chicago, Front Line event, laboratory equipment, lab suppliers, UChicago, BioResearch Product Faire, microbiome immunotherapy
Researchers around the world are constantly studying ways to create new treatment methods to fight cancer. With so many different forms of cancer, using one treatment method is not always effective for everyone battling this disease. Recently, a team of scientists in Chicago teamed up to create a new treatment method. Researchers from the University of Chicago and the biotechnology company Evelo Biosciences have partnered to develop a new microbiome-based immunotherapy treatment method for fighting cancer.
0 Comments Click here to read/write comments
Tags: Midwest, microbiome, immunotherapy, University of Chicago, cancer research, Chicago, Front Line event, IL, UChicago, 2016, BioResearch Product Faire, cancer therapy, Evelo Biosciences, microbiome immunotherapy